SearchContact usGeneral Inquiries Greater Montréal Area Greater Quebec Area Sherbrooke and Eastern
|
 BiopolisQuébec Directory
|
6100 Royalmount Avenue |
 |
Type of Organization Biotechnology Field of Activity
Therapeutic Therapeutic Application
Cardiology |
|
|
|
|
|
Corporate Overview
Milestone Pharmaceuticals Inc. (“Milestone�) is a drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases. Milestone’s lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as atrial arrhythmias and angina.
The Company has assembled a world-class scientific advisory board of key opinion leaders with significant cardiovascular expertise in cardiology, regulatory affairs, and drug development. Milestone has also assembled a panel of leading pharmaceutical drug development experts (“drug hunters�) who are current and former R&D executives from the pharmaceutical industry. The drug hunters identify and conceive NCE drug development projects based on clinically proven science to improve pharmacology profiles and/or reduce unwanted side effects through a focused medicinal chemistry approach. Milestone intends to develop these lead products into early clinical trials before licensing.
Location
